Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost Analysis.Published in:Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 4, p. 582, doi. 10.1002/cpt.875By:Ogungbenro, Kayode;Patel, Alkesh;Duncombe, Robert;Nuttall, Richard;Clark, James;Lorigan, PaulPublication type:Article